Delivery Order SPE2DB20D1109-SPE2DB25FP47V
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PRIORIX VIALS. The $11,510.43 firm-fixed-price delivery order has an ultimate completion date of February 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIORIX VIALS, a medical product, with a ceiling value of $18,540.20 and a period of performance through October 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded on October 28, 2024. The place of performance is Conshohocken, Pennsylvania....
- This federal contract award is for the delivery of PRIORIX VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,047.88 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $24,753 to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of July 30, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Priorix is a vaccine product, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,913.60 firm fixed-price delivery order is for the PRIORIX vaccine product. The contract has an ultimate completion date of August 23, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $27,668.94 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Priorix vials with a completion deadline of August 4, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.42, is for the delivery of PRIORIX vials, a vaccine product. It is a firm fixed-price delivery order contract type, with a completion date of March 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of PRIORIX Vials, a pharmaceutical product, to the government. The $3,028.26 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 9, 2025 and is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,395.00 firm fixed-price delivery order is for the supply of PRIORIX Vials, a pharmaceutical product. The award has an ultimate completion date of April 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $104,711.60 firm fixed-price delivery order is for the supply of PRIORIX VIALS, a medical product. The contract has an ultimate completion date of May 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP47VDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for PRIORIX vials valued at $4,854.20 under a firm fixed-price contract. The award was made on July 29, 2025, with an ultimate completion date of July 30, 2025. No set-aside designation was used for this competitive award. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This delivery order represents a child contract under a larger vehicle and is part of the company's extensive portfolio of pharmaceutical product deliveries to federal medical procurement programs. This award is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and related medical commodities to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its established capability to meet DLA medical supply requirements through open competitive procurement across multiple therapeutic domains and delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 7/29/25 |